Introduction
The mechanism by which venous disorders of the leg produce ulceration around the ankle is unknown. Ulceration is the final event in a-well-recognised series of changes in the skin and subcutaneous tissues. The first changes are cutaneous pigmentation, mild ankle oedema, and the appearance of dilated subdermal venules. Later the skin and subcutaneous fat becomes thickened and hard. Since the tissues are often red and tender Departments of Surgery, Physiology, and Dermatology, St Thomas's Hospital, London SEI K G BURNAND, MS, FRCS, assistant director, department of surgery I WHIMSTER, MB, MRCPATH, reader in pathology of the skin (Dr Whimster died in 1979) A NAIDOO, medical student N L BROWSE, MD, FRCS, professor of surgery they are mistakenly thought to be infected or to be the site of superficial thrombophlebitis. At this stage minor trauma will cause an ulcer. If ulceration does not occur the skin and fat contract and the patient develops a tight narrow gaiter of hard skin. We prefer to call this whole process "lipodermatosclerosis" rather than give each clinical phase a separate name.
In a series of experiments designed to elucidate the underlying cause of these changes we have shown that legs with poor calf pump function, as shown by the failure of exercise to reduce foot vein pressure, have an increased number of capillary loops within the ulcer-bearing skin.' Confirmation that this was a causal relation was obtained from an animal study in which an increase in the venous pressure produced a similar increase in the size of the capillary bed of the calf skin.2
Increasing the capillary pressure opens the intercellular endothelial pores and increases capillary permeability.3 4Studies in animals showed that the high intraluminal venous pressure and increased endothelial surface area available for exchange did not change the rate at which albumin and sodium escaped from the vascular compartment into the subcutaneous tissue fluid, but fibrinogen, a much larger molecule, accumulated significantly faster in the tissue fluid around the enlarged capillary bed. 2 The object of this study was to determine whether chronic venous hypertension and lipodermatosclerosis were associated with the accumulation of fibrinogen-fibrin in the perivascular interstitial spaces of human limbs.
Patients and methods
We studied 42 Thomas.6 The results of the clinical examination and phlebography were combined to classify all limbs into one of four categories, each reflecting an increasing degree of chronic venous hypertension: (a) normal limbs (not excluding those with occasional minor varicosities); (b) limbs without liposclerosis but with saphenous vein (long or short) incompetence and normal deep veins; (c) limbs with liposclerosis, saphenous vein (long and short) incompetence, and normal deep veins; and (d) limbs with liposclerosis and damaged deep veins.
Assessment of extravascularfibrin-Small biopsy specimens of skin (5 mm x 10 mm ellipses) were taken from the medial side of the calf of all 41 legs 7-5 cm vertically above the medial malleolus, a point which invariably coincided with the most severe liposclerosis when this was present. All the biopsies were stained with phosphotungstic acid haematoxylin (PTAH), which colours fibrin and related substances blue. The sections were then examined by one observer (IW), who was unaware of the other findings. Each specimen was reported as showing fibrin present or absent on this examination. The number of capillary vessels cut in cross section in each highpowered field was also assessed in arbitrary units, as previously described.' Biopsy specimens from two limbs with liposclerosis were examined for fibrin by an immunofluorescent technique using a rabbit-raised antifibrin7 and also studied with transmission electronmicroscopy. 8 The study was approved by the hospital ethical committee and all patients gave their informed written consent to the procedure. Fibrin and calf-pump efficiency-The mean reduction of foot vein pressure during exercise in the 26 legs with pericapillary fibrin was 17 2 ± 18% (SD), which was significantly less than the mean reduction of 54-6% ±20 in the 15 limbs without liposclerosis (t=6 006;p < 10-6).
Results

Clinical
Discussion
These studies show that fibrin is present in the skin of the ulcer-bearing area of the legs of all patients with lipodermatosclerosis. The fibrin is laid down as a cuff around the enlarged dermal capillary bed. We have previously presented experimental evidence that chronic venous hypertension increases the leakage of large molecules into the tissue spaces,2 and so we postulate that this accumulation of fibrin within the tissues is the result of greater quantities of fibrinogen escaping through capillary pores which are enlarged by the raised venous pressure.3' Since the fibrinolytic activity of the blood and the tissues is deficient in patients with lipodermatosclerosis,9 any fibrinogen which is converted to fibrin in the interstitial spaces is less likely to be broken down or reabsorbed.
The high venous oxygen tensions found in the venous blood of ulcerated limbs10 -13 could be explained if it were shown that fibrin prevents the passage of oxygen into the tissues, so turning the capillaries into physiological shunts. The Appendix contains the details of a simple experiment which shows that a 1-mm layer of fibrin reduces the diffusion of oxygen across a layer of water by a factor of 25. We therefore suggest that the pericapillary layer of fibrin acts as a diffusion barrier, leading to local tissue ischaemia, which is manifested as lipodermatosclerosis or ulceration.
If fibrin deposition can be reduced at an early stage, before it starts to kill tissue or stimulates irreversible fibrosis, venous ulceration may be prevented. This may be accomplished by surgical restoration of calf-pump efficiency, by the use of elastic compression, or by the use of drugs which enhance tissue fibrinolysis.14
Appendix
The permeability of a 1-mm thick commercial fibrin membrane (Ethicon Ltd) was tested for air, oxygen, and carbon dioxide in a specially designed diffusion chamber. A fugacity gradient was produced for each gas to maximise diffusion velocity through the aqueous media, and gas movement was measured by the displacement velocity of a meniscus formed within a volumetric capillary tube connected to the gas reservoir. Each gas was tested five times after initial measurements conducted with air diffusion and no membrane. The diffusion capacity of the fibrin was obtained by dividing the rate of gas diffusion in millilitres standard temperature and pressure in dry air per minute by the pressure difference across the membrane in mm Hg.
The diffusion capacity of both oxygen and air with no membrane in place was 5-04 x 10-s cm3/min/mm Hg, which fell to 0-228 x 1O-5 cm3/min/mm Hg when the membrane was inserted. The diffusion of carbon dioxide (0-699 x 10-5 cm3/min/mm Hg) was not affected by the membrane and was very similar to the diffusion capacity of carbon dioxide through the alveolar membrane (0 598 x 1O-5 cm3/min/ mm Hg).
A sheet of fibrin appears to allow carbon dioxide to pass through it relatively freely but is relatively impermeable to the passage of oxygen.
